Reshape Lifesciences Inc.
13F holders, Q1 2024 (March 31)18holders
1famous investor
$0.18avg. 13F price*
At the end of Q1 2024, 18 institutions reported holding Reshape Lifesciences Inc. in their 13F filings. The largest holders were Vanguard Group Inc. ($9K), Tower Research Capital LLC (TRC) ($9K) and BlackRock Inc. ($6K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Reshape Lifesciences Inc.
- CUSIP
- 76090R200
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $11K |
| Exits | 3 | $51K |
Ownership 18 holders
| Vanguard Group Inc. | 0.00% | No change | 49,874 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +190.4% | 49,569 | $9K |
| BlackRock Inc. | 0.00% | No change | 34,060 | $6K |
| Millennium Management | 0.00% | Add +40.6% | 29,785 | $5K |
| Goldman Sachs Group Inc. | 0.00% | New | 23,036 | $4K |
| Jane Street Group, LLC | 0.00% | New | 22,926 | $4K |
| Geode Capital Management, LLC | 0.00% | No change | 18,348 | $3K |
| State Street Corp. | 0.00% | No change | 13,015 | $2K |
| Two Sigma Securities, LLC | 0.00% | Reduce -83.0% | 12,820 | $2K |
| XTX Topco Ltd | 0.00% | New | 12,296 | $2K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -20.0% | 400 | $74 |
| Wells Fargo & Company | 0.00% | Add +81.2% | 183 | $34 |
| Cornerstone Planning Group LLC | 0.00% | New | 135 | $23 |
| Group One Trading LLC | 0.00% | No change | 3 | $1 |
| JPMorgan Chase & Co. | 0.00% | New | 1 | $0 |
| CIBC Private Wealth Group LLC | 0.00% | New | 1 | $0 |
| UBS Group AG | 0.00% | No change | 2 | $0 |
| Osaic Holdings, Inc. | 0.00% | No change | 5 | $0 |
"% of holder's portfolio" is RESHAPE LIFESCIENCES INC's weight in each manager's 13F, not the share of Reshape Lifesciences Inc. the manager owns.